Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Vineet Laboratories's Revenue for the
three
months ended in Dec. 2025 was ₹156.5 Mil. Vineet Laboratories's average Accounts Receivable for the
three
months ended in Dec. 2025 was ₹43.3 Mil.
Hence, Vineet Laboratories's Receivables Turnover for the
three
months ended in Dec. 2025 was 3.61.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Vineet Laboratories Receivables Turnover Related Terms
Vineet Laboratories Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:VINEETLAB vs DOW: Receivables Turnover Comparison
For the Chemicals subindustry, Vineet Laboratories's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vineet Laboratories (NSE:VINEETLAB) has a Receivables Turnover of 3.61 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vineet Laboratories and its competitors. According to the industry distribution chart, Vineet Laboratories ranks #1036 out of 1577 companies in the Chemicals industry, placing it in the top 65.7%.
Is Vineet Laboratories' Receivables Turnover too high?
Vineet Laboratories' current Receivables Turnover is 3.61. The Chemicals industry median Receivables Turnover is 5.59. Vineet Laboratories' value of 3.61 is 35.4% below this industry median. Based on the distribution chart, Vineet Laboratories ranks #1036 out of 1577 companies in the Chemicals industry, which is below the industry midpoint. Overall, Vineet Laboratories has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Receivables Turnover compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #1036 out of 1577 companies for Receivables Turnover. This places Vineet Laboratories in the lower half of its industry. The industry median Receivables Turnover is 5.59. Vineet Laboratories' value of 3.61 is 35.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.59, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current Receivables Turnover of 3.61 is 35.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vineet Laboratories and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current Receivables Turnover is 3.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.24, compared to a current price of ₹38.05 — trading 149.7% above its estimated fair value. The current Receivables Turnover is 3.61 and 35.4% below the Chemicals industry median of 5.59. Vineet Laboratories' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Receivables Turnover is 3.61 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹38.05 is trading 149.7% above its estimated GF Value™ of ₹15.24.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:VINEETLAB:
Receivables Turnover: 3.61
GF Value™: ₹15.24 vs. price of ₹38.05 (149.7% above fair value)
Industry Position: 35.4% below the Chemicals median (#1036 of 1577)
No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score
Get the complete analysis for NSE:VINEETLAB
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VINEETLAB has been successfully added to your 
